Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Offices
  4. /
  5. Office of Pharmaceutical Quality Operations Division I
FDA Office
•USA

Office of Pharmaceutical Quality Operations Division I

View detailed information about Office of Pharmaceutical Quality Operations Division I, including compliance records, people, and regulatory data.

Sign in to open in Dashboard
Office Profile

Comprehensive profile of Office of Pharmaceutical Quality Operations Division I, including its role, location, and regulatory activities.

Records (20)
EIR - MMC HEALTHCARE LTD.

Drugs • March 30, 2024

EIR
WARNING_LETTER - Max Chemical Inc.

Drugs • March 15, 2024

WARNING_LETTER
WARNING_LETTER - EyePoint Pharmaceuticals, Inc.

Drugs • February 15, 2024

WARNING_LETTER
483_RESPONSE - Wedgewood Connect, LLC

Drugs • November 17, 2023

483_RESPONSE
483 - Onkos Surgical, Inc.

drugs • October 26, 2023

483
WARNING_LETTER - ARG Laboratories, Inc.

Drugs • September 20, 2023

WARNING_LETTER
EIR - Advanced Accelerator Applications USA, Inc.

drugs • August 25, 2023

EIR
WARNING_LETTER - Northern VA Compounders PLLC

Drugs • December 9, 2022

WARNING_LETTER
EIR - Advanced Accelerator Applications USA, Inc.

drugs • November 3, 2022

EIR
483 - Cipla Limited

August 26, 2022

483
483 - Jubilant Generics Limited

August 1, 2022

483
WARNING_LETTER - Sovereign Pharmaceuticals, LLC

Drugs • April 22, 2022

WARNING_LETTER
WARNING_LETTER - Nephron Pharmaceuticals Corporation

Drugs • April 20, 2022

WARNING_LETTER
WARNING_LETTER - Nephron Sc Inc

Drugs • April 20, 2022

WARNING_LETTER
WARNING_LETTER - Sanitizer Supply LLC

Drugs • March 31, 2022

WARNING_LETTER
EIR - Frontage Laboratories, Inc.

Drugs • February 18, 2022

EIR
WARNING_LETTER - Bi-Coastal Pharma International

Drugs • January 14, 2022

WARNING_LETTER
WARNING_LETTER - Agropharma Laboratories, Inc.

Drugs • November 3, 2021

WARNING_LETTER
WARNING_LETTER - Vita Pharmacy, LLC dba Talon Pharmacy of Boerne

Drugs • November 2, 2021

WARNING_LETTER
WARNING_LETTER - Brigham and Women’s Hospital Inc.

Drugs • September 16, 2021

WARNING_LETTER

Showing 1 to 20 of 20 records

Related Offices (5)
Office of Compliance Intervention and Consultation
OCIC
Acting Division Director
Bureau of Environmental Health
Division of Nonprescription Drug Products
Division of Reproductive and Urologic Products
Office Information

Name

Office of Pharmaceutical Quality Operations Division I

Abbreviation

OPQO Division I

Country

USA

Postal Code

20993

State/Province

Maryland

City

Silver Spring

Address

10903 New Hampshire Avenue, WO66-5521

Office Website

Visit Website

ID: 798d6a62-d1f1-4f7c-8de3-465e277c13da

Get More Insights

Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more offices? Our platform provides access to hundreds of FDA offices with advanced search and filtering capabilities.

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.

KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.